Shared compound evidence record
Tirzepatide (20mg)
Metabolic Research
Loading the shop...
In Stock
Tirzepatide
40mg Lyophilised Powder
$249.99AUD per vial
Volume savings
Choose a tier to update your quantity.
Savings apply automatically. Prices in AUD.
1
1 vial · Item total$249.99 AUD
Express shipping $15.99 Australia-wide
No account needed. PayID or bank transfer instructions follow checkout.
Labelled quantity
40mg
Category
Metabolic Research
No published analytical document is currently linked
Availability
Ready to purchase now
In stock now and ready for checkout.
Same-day dispatch cutoff
Order within the current dispatch window
Melbourne cut-off time updates live every second.
Time Remaining
03:14:16
Frequently Bought Together
Stable research navigation
Connected catalogue records
These links are based on catalogue family, evidence records, research topics and bundle composition. They do not imply therapeutic similarity.
Connected compound evidence
Retatrutide (10mg)
Metabolic Research
Connected compound evidence
Retatrutide (20mg)
Metabolic Research
Connected compound evidence
Retatrutide (30mg)
Metabolic Research
Research library
Evidence and analytical context for this record
These resources separate compound identity, batch-quality questions and study evidence. A linked study does not establish that this catalogue material is equivalent to a medicine or investigational product.
Product Information
Tirzepatide (40mg): laboratory research material
Tirzepatide is a synthetic peptide investigated at the GIP and GLP-1 receptors. This research-material listing should be distinguished from finished pharmaceutical products and their formulation-specific evidence.
Presentation and analytical documentation
Supplied as a lyophilised powder. The product name states the nominal quantity for this catalogue format. Review the analytical-document status and the CoA library for available sample reports. Read the identifiers, methods and measured results in the actual report; do not assume that one record covers every vial or batch.
Research context
Compare the nominal mass, presentation and supporting analytical record for each vial. A shared ingredient name does not establish equivalence to a pharmaceutical product or validate an experimental method. Consult the Tirzepatide research guide for source context and evidence limits.
Laboratory preparation and storage
Use the material-specific documentation and a validated laboratory method to select solvent, concentration and storage conditions. Keep the sample identifier and preparation record with the experimental data. A labelled mass or purity result does not establish solution stability, sterility or suitability for a particular assay.
For laboratory research only. Not for human or veterinary use.
Frequently Asked Questions
What is Tirzepatide?
Tirzepatide is a synthetic peptide investigated at the GIP and GLP-1 receptors. This research-material listing should be distinguished from finished pharmaceutical products and their formulation-specific evidence.